Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 26, 2024

SELL
$164.52 - $238.84 $326,901 - $474,575
-1,987 Reduced 64.06%
1,115 $263,000
Q3 2023

Nov 07, 2023

SELL
$194.44 - $217.61 $27,416 - $30,683
-141 Reduced 4.35%
3,102 $607,000
Q2 2023

Aug 07, 2023

SELL
$183.71 - $210.25 $7,164 - $8,199
-39 Reduced 1.19%
3,243 $681,000
Q1 2023

May 10, 2023

BUY
$191.89 - $259.92 $216,260 - $292,929
1,127 Added 52.3%
3,282 $662,000
Q4 2022

Feb 09, 2023

BUY
$197.11 - $250.07 $424,772 - $538,900
2,155 New
2,155 $469,000
Q1 2022

May 16, 2022

SELL
$255.51 - $362.11 $1,277 - $1,810
-5 Reduced 0.53%
945 $268,000
Q4 2021

Feb 14, 2022

SELL
$351.38 - $448.68 $9,135 - $11,665
-26 Reduced 2.66%
950 $358,000
Q1 2021

May 14, 2021

BUY
$249.67 - $299.48 $243,677 - $292,292
976 New
976 $283,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.49B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Impax Asset Management Group PLC Portfolio

Follow Impax Asset Management Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Impax Asset Management Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Impax Asset Management Group PLC with notifications on news.